Co-Activation of Cultured Human Natural Killer Cells: Enhanced Function and Decreased Inhibition

Journal of Toxicology and Environmental Health - Part A: Current Issues

Volumn 79, Issue 22-23, 2016, Pages 1078-1084

  Urlaub, Doris ^a   Bhat, Rauf ^b,c   Messmer, Birgitta ^b   Watzl, Carsten ^a  

^a TU DORTMUND UNIVERSITY   (Germany)

^b UNIVERSITY HOSPITAL HEIDELBERG   (Germany)

^c GERMAN CANCER RESEARCH CENTER DKFZ   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

INTERLEUKIN 2; MITOGEN ACTIVATED PROTEIN KINASE; PROTEIN; UNCLASSIFIED DRUG; VAV 1 PROTEIN; NATURAL KILLER CELL RECEPTOR; VAV PROTEIN; VAV1 PROTEIN, HUMAN;

ARTICLE; CELL ACTIVATION; CELL KILLING; CONTROLLED STUDY; DEGRANULATION; HUMAN; HUMAN CELL; HUMAN CELL CULTURE; LYMPHOCYTE FUNCTION; NATURAL KILLER CELL; PRIORITY JOURNAL; PROTEIN CROSS LINKING; PROTEIN PHOSPHORYLATION; SIGNAL TRANSDUCTION; TARGET CELL; GENETICS; METABOLISM; PHOSPHORYLATION;

HUMANS; KILLER CELLS, NATURAL; MAP KINASE SIGNALING SYSTEM; PHOSPHORYLATION; PROTO-ONCOGENE PROTEINS C-VAV; RECEPTORS, NATURAL KILLER CELL; SIGNAL TRANSDUCTION;

EID: 85002541606     PISSN: 15287394     EISSN: 10872620     Source Type: Journal    
DOI: 10.1080/15287394.2016.1219587     Document Type: Article

References (27)

1. Bryceson, Y. T., March, M. E., Ljunggren, H. G., and Long, E. O., 2006a. Activation, coactivation, and costimulation of resting human natural killer cells. Immunol. Rev. 214:73–91.
2. Bryceson, Y. T., March, M. E., Ljunggren, H. G., and Long, E. O., 2006b. Synergy among receptors on resting NK cells for the activation of natural cytotoxicity and cytokine secretion. Blood 107:159–166.
3. Cederbrant, K., Marcusson-Stahl, M., Condevaux, F., and Descotes, J., 2003. NK-cell activity in immunotoxicity drug evaluation. Toxicology 185:241–250.
4. Coelho, P., Garcia-Leston, J., Costa, S., Costa, C., Silva, S., Fuchs, D., and Geisler, S., 2014. Immunological alterations in individuals exposed to metal(loid)s in the Panasqueira mining area, central Portugal. Sci. Total. Environ. 475:1–7.
5. Cohnen, A., Chiang, S. C., Stojanovic, A., Schmidt, H., Claus, M., Saftig, P., Janssen, O., Cerwenka, A., Bryceson, Y. T., and Watzl, C., 2013. Surface CD107a/LAMP-1 protects natural killer cells from degranulation-associated damage. Blood 122:1411–1418.
6. Eissmann, P., and Watzl, C., 2006. Molecular analysis of NTB-A signaling:A role for EAT-2 in NTB-A-mediated activation of human NK cells. J. Immunol. 177:3170–3177.
7. European Medicines Agency. 2000. Note for guidance on repeated dose toxicity. CPMP/SWP/1042/99. EMEA. www.ema.europa.eu/ema/index.jsp?curl=pages/includes/document/document_detail.jsp?webContentId=WC500003102&mid=WC0b01ac058009a3dcoralternativelyjustwww.ema.europa.eu/ema/
8. Endt, J., McCann, F. E., Almeida, C. R., Urlaub, D., Leung, R., Pende, D., Davis, D. M., and Watzl, C., 2007. Inhibitory receptor signals suppress ligation-induced recruitment of NKG2D to GM1-rich membrane domains at the human NK cell immune synapse. J. Immunol. 178:5606–5611.
9. Kim, H. S., Das, A., Gross, C. C., Bryceson, Y. T., and Long, E. O., 2010. Synergistic signals for natural cytotoxicity are required to overcome inhibition by c-Cbl ubiquitin ligase. Immunity 32:175–186.
10. Kim, H. S., and Long, E. O., 2012. Complementary phosphorylation sites in the adaptor protein SLP-76 promote synergistic activation of natural killer cells. Sci. Signal. 5:ra49.
11. Koch, J., Steinle, A., Watzl, C., and Mandelboim, O., 2013. Activating natural cytotoxicity receptors of natural killer cells in cancer and infection. Trends Immunol. 34:182–191.
12. Kruse, P. H., Matta, J., Ugolini, S., and Vivier, E., 2014. Natural cytotoxicity receptors and their ligands. Immunol. Cell Biol. 92:221–229.
13. Laffon, B., Aguilera, F., Rios-Vazquez, J., Garcia-Leston, J., Fuchs, D., Valdiglesias, V., and Pasaro, E., 2013. Endocrine and immunological parameters in individuals involved in Prestige spill cleanup tasks seven years after the exposure. Environ. Int. 59:103–111.
14. Long, E. O., Kim, H. S., Liu, D., Peterson, M. E., and Rajagopalan, S., 2013. Controlling natural killer cell responses:Integration of signals for activation and inhibition. Annu. Rev. Immunol. 31:227–258.
15. Mace, E. M., Dongre, P., Hsu, H. T., Sinha, P., James, A. M., Mann, S. S., Forbes, L. R., Watkin, L. B., and Orange, J. S., 2014. Cell biological steps and checkpoints in accessing NK cell cytotoxicity. Immunol. Cell Biol. 92:245–255.
16. Mesecke, S., Urlaub, D., Busch, H., Eils, R., and Watzl, C., 2011. Integration of activating and inhibitory receptor signaling by regulated phosphorylation of Vav1 in immune cells. Sci. Signal. 4:ra36.
17. Messmer, B., Eissmann, P., Stark, S., and Watzl, C., 2006. CD48 stimulation by 2B4 (CD244)-expressing targets activates human NK cells. J. Immunol. 176:4646–4650.
18. Romagne, F., and Vivier, E., 2011. Natural killer cell-based therapies. F1000 Med. Rep. 3:9.
19. Sandusky, M. M., Messmer, B., and Watzl, C., 2006. Regulation of 2B4 (CD244)-mediated NK cell activation by ligand-induced receptor modulation. Eur. J. Immunol. 36:3268–3276.
20. Stebbins, C. C., Watzl, C., Billadeau, D. D., Leibson, P. J., Burshtyn, D. N., and Long, E. O., 2003. Vav1 dephosphorylation by the tyrosine phosphatase SHP-1 as a mechanism for inhibition of cellular cytotoxicity. Mol. Cell. Biol. 23:6291–6299.
21. Vivier, E., Tomasello, E., Baratin, M., Walzer, T., and Ugolini, S., 2008. Functions of natural killer cells. Nat. Immunol. 9:503–510.
22. Watzl, C., 2014. How to trigger a killer:Modulation of natural killer cell reactivity on many levels. Adv. Immunol. 124:137–170.
23. Watzl, C., and Long, E. O., 2003. Natural killer cell inhibitory receptors block actin cytoskeleton-dependent recruitment of 2B4 (CD244) to lipid rafts. J. Exp. Med. 197:77–85.
24. Watzl, C., and Long, E. O., 2010. Signal transduction during activation and inhibition of natural killer cells. Curr. Protocols Immunol. Chapter 11:Unit11.9B.
25. Watzl, C., Stebbins, C. C., and Long, E. O., 2000. NK cell inhibitory receptors prevent tyrosine phosphorylation of the activation receptor 2B4 (CD244). J. Immunol. 165:3545–3548.
26. Watzl, C., and Urlaub, D., 2012. Molecular mechanisms of natural killer cell regulation. Front. Biosci. (Landmark Ed.) 17:1418–1432.
27. Wei, S., Gilvary, D. L., Corliss, B. C., Sebti, S., Sun, J., Straus, D. B., and Leibson, P. J., 2000. Direct tumor lysis by NK cells uses a Ras-independent mitogen-activated protein kinase signal pathway. J. Immunol. 165:3811–3819.